| Name | Title | Contact Details |
|---|
Avantra is the industry-leading AIOps platform for SAP Operations: helping companies transform into a self-healing enterprise.
Blackbird.AI is a company that provides a Narrative & Risk Intelligence platform that empowers organizations to identify and measure manipulation of social and public perception through the lens of risk and opportunity.
A market-leading AI recruiting company with a focus on sourcing and hiring quality candidates faster & easier through automated sourcing and AI-driven solutions.
Mobivity helps restaurant and retail brands grow their business by increasing customer frequency, engagement and spend. Mobivitys Smart suite of products - including SmartReceipt™, SmartSMS, and SmartAnalytics - allows brands to unlock the power of cu...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.